Companies / BOC Sciences / (Gly21)-Amyloid _-Protein (1-42)
BOC Sciences

(Gly21)-Amyloid _-Protein (1-42) | BOC Sciences

The Flemish mutation (A21G) displays a decreased tendency to aggregate and a reduced neurotoxicity. A21G is pathogenic because it is degraded by Neprilysin significantly more slowly than WT Abeta42.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.